REG - JP Morgan Sec LLC Willis Towers Watson - Willis Towers Watson plc 8.3

Willis Towers WatsonAnnouncement

10/06/2021 13:10

RNS Number : 5255B
  
J.P. Morgan Securities LLC
  
10 June 2021
  
 

Ap19
 
 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


J.P. Morgan Securities LLC




Company dealt in


Willis Towers Watson plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.000304635 ordinary shares




Date of dealing


09 June 2021




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


1,909,998                1.48
 


1,629,565             1.26
 




(2) Derivatives (other than options)


1,467,204                1.14
 


1,727,583                1.34
 




(3) Options and agreements to purchase/sell
 


14,000             0.01
 


 




Total


3,391,202             2.63
 


3,357,148             2.60
 



 
 
 
 
 
 
 



 

 

Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales
 




 
Purchase/sale


 
Number of relevant securities


 
Price per unit (USD)
 
(Note 5)




Purchase (Loan Return)
 
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
 
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales


100
 
100 
 100 
 37 
 100 
 100 
 100 
 85 
 63 
 100 
 100 
 22 
 32 
 1 
 1 
 292 
 103 
 162 
 13 
 162 
 62 
 388 
 4 
 
 100 
 100 
 22 
 32 
 1 
 410 
 131 
 243 
 388 
 12 
 257 
 4 
 4 
 4


N/A
 
255.4075     USD
255.3964     USD
255.3910     USD
255.2554     USD
255.1811     USD
255.1700     USD
255.0561     USD
255.0409     USD
254.8200     USD
254.8100     USD
254.7300     USD
254.5700     USD
254.5400     USD
254.5300     USD
254.5100     USD
254.4303     USD
254.4062     USD
254.3900     USD
254.2600     USD
254.2373     USD
254.2046     USD
253.9075     USD
                        
254.8200     USD
254.8100     USD
254.7300     USD
254.5700     USD
254.5400     USD
254.5100     USD
254.3591     USD
254.2600     USD
254.2046     USD
254.1750     USD
254.1711     USD
253.9300     USD
253.9075     USD
253.3550     USD




 
 
 
 
 
 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(USD) (Note 5)




Equity Swap


Increase Long
 
Decrease Short


388 
 
 4


254.2046     USD
                        
253.9300     USD




 
 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price (USD)


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5) (USD)




 


 


 


 


 


 


 




 
 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




 


 


 




 
                          
 
Ap21
 
2.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 
     None
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            Yes
 




Date of disclosure


10 June 2021




Contact name


Alwyn Basch




Telephone number


0207 742 7407




If a connected EFM, name of offeree/offeror with which connected


N/A




If a connected EFM, state nature of connection (Note 10)


N/A




 
 
 
 
 
 
 
 
SUPPLEMENTAL FORM 8
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
 
 
 
DETAILS OF OPEN POSITIONS
 
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
 
OPEN POSITIONS (Note 1)
 
 
 




Product name,
e.g. call option


Written, or purchased


Number of relevant securities to which the option or derivative relates


Exercise price (Note 2) (USD)


Type, e.g. American, European etc.


Expiry date




Call Option
Put Option
Put Option


Purchased
Purchased
Purchased


2,000
2,000
10,000


290.00
230.00
260.00


American
American
American


18/06/2021
18/06/2021
18/06/2021




 
 
Notes
 
1.        Where there are open option positions or open derivative positions (except for CFDs), full details should be given. 
         Full details of any existing agreements to purchase or to sell must also be given on this form.
 
2.        For all prices and other monetary amounts, the currency must be stated.
 
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISELBLFFFQLBBBX